Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery

scientific article published on 26 May 2012

Toxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11095-012-0791-8
P698PubMed publication ID22638871

P50authorIván PeñuelasQ42946736
Juan M. IracheQ43161954
P2093author name stringPaloma Areses
Adela López de Cerain
Patricia Ojer
P2860cites workDrug delivery and nanoparticles:applications and hazardsQ24655744
Nanoparticles: pharmacological and toxicological significanceQ24681563
An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles.Q31116672
Nanomedicine: current status and future prospects.Q34399915
Biomedical applications and potential health risks of nanomaterials: molecular mechanismsQ36615255
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.Q36627730
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug deliveryQ37015849
Biodegradable polymeric nanoparticles based drug delivery systemsQ37603750
Biodegradation, biodistribution and toxicity of chitosanQ37607576
Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicitiesQ37705487
Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternativeQ37760469
Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscaleQ37877717
Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugsQ37922723
Biocompatible gellan gum-reduced gold nanoparticles: cellular uptake and subacute oral toxicity studies.Q39630206
Polymeric nanoparticles for drug delivery.Q39729803
Correlating physico-chemical with toxicological properties of nanoparticles: the present and the futureQ39824495
Curcumin-Loaded Hydrogel Nanoparticles: Application in Anti-Malarial Therapy and Toxicological EvaluationQ42915648
Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxelQ43274430
Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugatesQ44185143
Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidinesQ44828762
Simultaneous quantification of different cyclodextrins and Gantrez by HPLC with evaporative light scattering detectionQ46537330
Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice.Q46705660
Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 ratsQ48344214
Acute and subacute toxicity studies of chitosan reduced gold nanoparticles: a novel carrier for therapeutic agents.Q51593386
Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration.Q51771964
European and international standardisation progress in the field of engineered nanoparticles.Q51823039
Molecular imaging techniques to study the biodistribution of orally administered (99m)Tc-labelled naive and ligand-tagged nanoparticles.Q53255030
Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.Q54018618
Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergensQ57216501
Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomesQ71499864
The clinical effectiveness of a dentifrice containing triclosan and a copolymer for controlling breath odor measured organoleptically twelve hours after toothbrushingQ73823088
Development of bioadhesive amino-pegylated poly(anhydride) nanoparticles designed for oral DNA deliveryQ80623518
Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive propertiesQ81561725
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin deliveryQ83256058
Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticlesQ83937655
Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquoneQ84577974
P433issue9
P921main subjectnanoparticleQ61231
drug deliveryQ1392806
P304page(s)2615-2627
P577publication date2012-05-26
P1433published inPharmaceutical ResearchQ7180737
P1476titleToxicity studies of poly(anhydride) nanoparticles as carriers for oral drug delivery
P478volume29

Reverse relations

cites work (P2860)
Q39151158Adjuvants for allergy immunotherapeutics.
Q43623067Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice

Search more.